Mereo BioPharma Group plc (NASDAQ: MREO) is 36.00% higher on its value in year-to-date trading and has touched a low of $0.30 and a high of $1.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MREO stock was last observed hovering at around $0.97 in the last trading session, with the day’s gains setting it 0.05% off its average median price target of $4.00 for the next 12 months. It is also 79.6% off the consensus price target high of $5.00 offered by 4 analysts, but current levels are 74.5% higher than the price target low of $4.00 for the same period.
Currently trading at $1.02, the stock is 33.68% and 33.91% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.33 million and changing 5.15% at the moment leaves the stock 8.99% off its SMA200. MREO registered -18.40% loss for a year compared to 6-month loss of -34.62%.
The stock witnessed a 92.45% gain in the last 1 month and extending the period to 3 months gives it a 4.51%, and is 14.90% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.10% over the week and 17.01% over the month.
Mereo BioPharma Group plc (MREO) has around 49 employees, a market worth around $127.49M and $0.00M in sales. Current P/E ratio is 9.27. Distance from 52-week low is 238.87% and -44.86% from its 52-week high.
Mereo BioPharma Group plc (MREO) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Mereo BioPharma Group plc (MREO) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Mereo BioPharma Group plc (MREO) Top Institutional Holders
The shares outstanding are 124.99M, and float is at 124.99M with Short Float at 2.79%.